The Prevalence Overexpression Of C-Erbb-2 Oncoprotein In Carcinoma Of The Prostate-Mulago Hospital

Abstract

Over expression of C-erbB-2 a Human epidermal growth factor has been reported in several human carcinomas including prostate cancer. In prostate cancer studies have for it to have a prognostic role and to predict likelihood of resistance in hormonal therapy. The oncoprotein receptors are now being looked at as possibility of prognostic predictor at the same time as a target for therapy in cancers.